Search research articles
Contact Us
Filters
Showing results (81-90 of 143) with videos related to
Page
of 15
Sort By:
Nature Communications
|
March 12, 2015
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
Wei Gao, Zhewei Tang, Yi-Fan Zhang, et al.
Antibody Therapeutics
|
February 26, 2019
Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies
Emily Weiss, Robert Sarnovsky, Mitchell Ho, et al.
Antibody Therapeutics
|
November 9, 2018
Frontiers and Opportunities: Highlights of the 2<sup>nd</sup> Annual Conference of the Chinese Antibody Society
Hongyu Zhang, Mi Deng, Peng Lin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 16, 2023
Identification of nurse shark V<sub>NAR</sub> single-domain antibodies targeting the spike S2 subunit of SARS-CoV-2
Jesse Buffington, Zhijian Duan, Hyung Joon Kwon, et al.
Cancer Research
|
January 28, 2010
A flow cytometry method to quantitate internalized immunotoxins shows that taxol synergistically increases cellular immunotoxins uptake
Yujian Zhang, Johanna K Hansen, Laiman Xiang, et al.
Journal of Cancer
|
May 26, 2011
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
Xinran Xiang, Mingqian Feng, Mildred Felder, et al.
Antibody Therapeutics
|
January 19, 2026
RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy
Masanori Onda, Xiufen Liu, Wenlong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin
Junko Yokokawa, Claudia Palena, Philip Arlen, et al.
Molecular Therapy. Oncology
|
November 11, 2024
CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer
Zhijian Duan, Dan Li, Nan Li, et al.
Journal for Immunotherapy of Cancer
|
July 23, 2024
rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors
Dan Li, Tianyuzhou Liang, Laura E Hutchins, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 143) with videos related to
Sort By:
Page
of 15
Nature Communications
|
March 12, 2015
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
Wei Gao, Zhewei Tang, Yi-Fan Zhang, et al.
Antibody Therapeutics
|
February 26, 2019
Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies
Emily Weiss, Robert Sarnovsky, Mitchell Ho, et al.
Antibody Therapeutics
|
November 9, 2018
Frontiers and Opportunities: Highlights of the 2<sup>nd</sup> Annual Conference of the Chinese Antibody Society
Hongyu Zhang, Mi Deng, Peng Lin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 16, 2023
Identification of nurse shark V<sub>NAR</sub> single-domain antibodies targeting the spike S2 subunit of SARS-CoV-2
Jesse Buffington, Zhijian Duan, Hyung Joon Kwon, et al.
Cancer Research
|
January 28, 2010
A flow cytometry method to quantitate internalized immunotoxins shows that taxol synergistically increases cellular immunotoxins uptake
Yujian Zhang, Johanna K Hansen, Laiman Xiang, et al.
Journal of Cancer
|
May 26, 2011
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
Xinran Xiang, Mingqian Feng, Mildred Felder, et al.
Antibody Therapeutics
|
January 19, 2026
RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy
Masanori Onda, Xiufen Liu, Wenlong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
Identification of novel human CTL epitopes and their agonist epitopes of mesothelin
Junko Yokokawa, Claudia Palena, Philip Arlen, et al.
Molecular Therapy. Oncology
|
November 11, 2024
CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer
Zhijian Duan, Dan Li, Nan Li, et al.
Journal for Immunotherapy of Cancer
|
July 23, 2024
rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors
Dan Li, Tianyuzhou Liang, Laura E Hutchins, et al.
Page
of 15